Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation.
Xu
M
M
Liver & Hepatobiliary Unit, Queen Elizabeth Hospital and Medical Center, Birmingham, United Kingdom.
Antoniou
E A
EA
Afford
S C
SC
Suzuki
S
S
Pirenne
J
J
McMaster
P
P
D'Silva
M
M
D000005:Abdomen; D000818:Animals; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D000068876:Fingolimod Hydrochloride; D006085:Graft Survival / Q000187:drug effects* / Q000276:immunology; D016027:Heart Transplantation / Q000276:immunology*; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007432:Intraoperative Period; D007677:Kidney Function Tests; D008111:Liver Function Tests; D011409:Propylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D011919:Rats, Inbred Strains; D012044:Regression Analysis; D013110:Sphingosine / Q000031:analogs & derivatives; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D016042:Transplantation, Heterotopic; D014184:Transplantation, Homologous; D015430:Weight Gain / Q000187:drug effects
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; D016559:Tacrolimus